Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

TG Therapeutics, Inc. (TGTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.43-0.35 (-4.50%)
At close: 04:00PM EDT
7.59 +0.16 (+2.15%)
After hours: 05:41PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Engulfing Line (Bearish)

Engulfing Line (Bearish)

Previous Close7.78
Open7.60
Bid7.37 x 800
Ask7.58 x 1400
Day's Range7.36 - 7.82
52 Week Range3.48 - 35.94
Volume1,946,692
Avg. Volume3,356,703
Market Cap1.079B
Beta (5Y Monthly)2.27
PE Ratio (TTM)N/A
EPS (TTM)-2.46
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TGTX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • TG Therapeutics, Inc.
    Analyst Report: Vertex Pharmaceuticals, Inc.Vertex Pharmaceuticals develops therapies to address cystic fibrosis and other diseases. The company was founded in 1989 in Cambridge, Massachusetts and has 3,500 employees. It has research programs and facilities in the U.S., the U.K., and Canada. The shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
Advertisement
Advertisement